FFCP PHASE1:Mm9::chr11:118007387..118007405,+: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|EntrezGene=NA|HGNC=|MCL_coexpression_id=6|UniProt=NA|association_with_transcript=NA|description=CAGE_peak_at_chr11:118007387..118007405,+|id=chr11:118007387..118007405,+|ontology_enrichment_celltype=CL:0000988!5.18e-22!32;CL:0002032!5.18e-22!32;CL:0000037!5.18e-22!32;CL:0000566!5.18e-22!32;CL:0000837!5.18e-22!32;CL:0002031!5.79e-17!25;CL:0002320!3.61e-16!46;CL:0000134!3.61e-16!46;CL:0000791!7.04e-15!9;CL:0000789!7.04e-15!9;CL:0002420!7.04e-15!9;CL:0002419!7.04e-15!9;CL:0000790!7.04e-15!9;CL:0000838!2.36e-14!12;CL:0000219!3.40e-13!54;CL:0000542!3.78e-13!13;CL:0000051!3.78e-13!13;CL:0000624!2.64e-12!8;CL:0000084!5.36e-12!11;CL:0000827!5.36e-12!11;CL:0000553!6.46e-12!6;CL:0000556!6.46e-12!6;CL:0000063!2.24e-11!66;CL:0000034!6.76e-11!97;CL:0000049!2.43e-10!19;CL:0000738!9.48e-10!17;CL:0002087!9.48e-10!17;CL:0000723!1.56e-09!91;CL:0000048!1.56e-09!91;CL:0002027!3.69e-09!3;CL:0002006!3.69e-09!3;CL:0002024!3.69e-09!3;CL:0000144!1.18e-08!121;CL:0000012!1.18e-08!121;CL:0000050!7.74e-08!9;CL:0000763!9.64e-08!16;CL:0000893!1.31e-07!6;CL:0002489!1.31e-07!6;CL:0000898!1.31e-07!6;CL:0000809!1.31e-07!6;CL:0000810!1.31e-07!6;CL:0000895!1.31e-07!6;CL:0000808!1.31e-07!6;CL:0000894!1.31e-07!6;CL:0000806!1.31e-07!6;CL:0000807!1.31e-07!6;CL:0000805!1.31e-07!6;CL:0002425!1.31e-07!6;CL:0002436!1.31e-07!6;CL:0002427!1.31e-07!6;CL:0002428!1.31e-07!6;CL:0002429!1.31e-07!6;CL:0002433!1.31e-07!6;CL:0002431!1.31e-07!6;CL:0002432!1.31e-07!6;CL:0002371!3.95e-07!118|ontology_enrichment_celltype_v019_2=CL:0000838,7.02e-14,12;CL:0000542,8.15e-13,13;CL:0000051,8.15e-13,13;CL:0002031,1.77e-12,25;CL:0000791,4.24e-12,9;CL:0000789,4.24e-12,9;CL:0002420,4.24e-12,9;CL:0002419,4.24e-12,9;CL:0000790,4.24e-12,9;CL:0000084,5.98e-10,11;CL:0000827,5.98e-10,11;CL:0000738,8.44e-10,17;CL:0002087,8.44e-10,17;CL:0000988,1.21e-09,32;CL:0002032,1.21e-09,32;CL:0000037,1.21e-09,32;CL:0000837,1.21e-09,32;CL:0000625,4.10e-08,1;CL:0000945,4.80e-08,1;CL:0000236,4.80e-08,1;CL:0000826,4.80e-08,1;CL:0000624,5.29e-08,8;CL:0000355,1.61e-07,9|ontology_enrichment_disease=DOID:0060100!3.62e-10!3;DOID:4045!3.62e-10!3|ontology_enrichment_disease_v019_2=DOID:0060100,2.08e-21,3;DOID:4045,2.08e-21,3;DOID:0050686,5.11e-11,6|ontology_enrichment_uberon=UBERON:0002384!3.61e-16!46;UBERON:0002204!1.35e-10!32;UBERON:0002371!4.00e-10!16;UBERON:0001474!5.05e-07!22;UBERON:0004765!5.05e-07!22;UBERON:0001434!5.05e-07!22|ontology_enrichment_uberon_v019_2=UBERON:0001134,1.61e-07,9;UBERON:0002036,1.61e-07,9;UBERON:0002385,1.61e-07,9;UBERON:0000486,1.61e-07,9;UBERON:0007503,1.61e-07,9;UBERON:0001015,1.61e-07,9;UBERON:0002329,1.61e-07,9;UBERON:0003082,1.61e-07,9;UBERON:0003059,1.61e-07,9;UBERON:0007282,1.61e-07,9;UBERON:0004290,1.61e-07,9;UBERON:0009618,1.61e-07,9;UBERON:0000383,8.12e-07,10|phase1_expression=0,0,0,0,0,0,0,0.774739940649458,0.281577444303333,0.234064526321993,0,0,1.36960583944965,1.39872643870396,0.666219523631325,1.01237633694913,0.699561878128147,0.788655413395594,1.37114433605739,0,0,0,0,0,0,0,0,0.215471232685889,0,0,0,0,0,0,0,0,0,8.78916424547506,4.6880120671428,6.28228492768558,38.8232782100469,37.5675016727145,15.0508209439658,0,0,0,0,0,0,0,0,0,2.01339127269284,1.45072428402269,2.01656279485478,0,0,0,0,0,0,0,0,0,0.988866362566974,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.479260498023681,0,0.254140454146129,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.189106080167819,0,0,0,0,0,0,0,0.257347907114715,0.284163499395593,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.324270453550071,0,0,0,0,0,0,0,0.554259570499814,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.252470927204373,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.849892149969277,0.279902904647316,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.409231043169689,0,0,0,0,0,0,0,0|short_description=p@chr11:118007387..118007405,+}} | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=NA | |||
|HGNC= | |||
|MCL_coexpression_id=6 | |||
|TSSclassifier=NA | |||
|UniProt=NA | |||
|association_with_transcript=NA | |||
|cluster_id=chr11:118007387..118007405,+ | |||
|description=CAGE_peak_at_chr11:118007387..118007405,+ | |||
|id=chr11:118007387..118007405,+ | |||
|ontology_enrichment_celltype=CL:0000988!5.18e-22!32;CL:0002032!5.18e-22!32;CL:0000037!5.18e-22!32;CL:0000566!5.18e-22!32;CL:0000837!5.18e-22!32;CL:0002031!5.79e-17!25;CL:0002320!3.61e-16!46;CL:0000134!3.61e-16!46;CL:0000791!7.04e-15!9;CL:0000789!7.04e-15!9;CL:0002420!7.04e-15!9;CL:0002419!7.04e-15!9;CL:0000790!7.04e-15!9;CL:0000838!2.36e-14!12;CL:0000219!3.40e-13!54;CL:0000542!3.78e-13!13;CL:0000051!3.78e-13!13;CL:0000624!2.64e-12!8;CL:0000084!5.36e-12!11;CL:0000827!5.36e-12!11;CL:0000553!6.46e-12!6;CL:0000556!6.46e-12!6;CL:0000063!2.24e-11!66;CL:0000034!6.76e-11!97;CL:0000049!2.43e-10!19;CL:0000738!9.48e-10!17;CL:0002087!9.48e-10!17;CL:0000723!1.56e-09!91;CL:0000048!1.56e-09!91;CL:0002027!3.69e-09!3;CL:0002006!3.69e-09!3;CL:0002024!3.69e-09!3;CL:0000144!1.18e-08!121;CL:0000012!1.18e-08!121;CL:0000050!7.74e-08!9;CL:0000763!9.64e-08!16;CL:0000893!1.31e-07!6;CL:0002489!1.31e-07!6;CL:0000898!1.31e-07!6;CL:0000809!1.31e-07!6;CL:0000810!1.31e-07!6;CL:0000895!1.31e-07!6;CL:0000808!1.31e-07!6;CL:0000894!1.31e-07!6;CL:0000806!1.31e-07!6;CL:0000807!1.31e-07!6;CL:0000805!1.31e-07!6;CL:0002425!1.31e-07!6;CL:0002436!1.31e-07!6;CL:0002427!1.31e-07!6;CL:0002428!1.31e-07!6;CL:0002429!1.31e-07!6;CL:0002433!1.31e-07!6;CL:0002431!1.31e-07!6;CL:0002432!1.31e-07!6;CL:0002371!3.95e-07!118 | |||
|ontology_enrichment_celltype_v019_2=CL:0000838,7.02e-14,12;CL:0000542,8.15e-13,13;CL:0000051,8.15e-13,13;CL:0002031,1.77e-12,25;CL:0000791,4.24e-12,9;CL:0000789,4.24e-12,9;CL:0002420,4.24e-12,9;CL:0002419,4.24e-12,9;CL:0000790,4.24e-12,9;CL:0000084,5.98e-10,11;CL:0000827,5.98e-10,11;CL:0000738,8.44e-10,17;CL:0002087,8.44e-10,17;CL:0000988,1.21e-09,32;CL:0002032,1.21e-09,32;CL:0000037,1.21e-09,32;CL:0000837,1.21e-09,32;CL:0000625,4.10e-08,1;CL:0000945,4.80e-08,1;CL:0000236,4.80e-08,1;CL:0000826,4.80e-08,1;CL:0000624,5.29e-08,8;CL:0000355,1.61e-07,9 | |||
|ontology_enrichment_disease=DOID:0060100!3.62e-10!3;DOID:4045!3.62e-10!3 | |||
|ontology_enrichment_disease_v019_2=DOID:0060100,2.08e-21,3;DOID:4045,2.08e-21,3;DOID:0050686,5.11e-11,6 | |||
|ontology_enrichment_uberon=UBERON:0002384!3.61e-16!46;UBERON:0002204!1.35e-10!32;UBERON:0002371!4.00e-10!16;UBERON:0001474!5.05e-07!22;UBERON:0004765!5.05e-07!22;UBERON:0001434!5.05e-07!22 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0001134,1.61e-07,9;UBERON:0002036,1.61e-07,9;UBERON:0002385,1.61e-07,9;UBERON:0000486,1.61e-07,9;UBERON:0007503,1.61e-07,9;UBERON:0001015,1.61e-07,9;UBERON:0002329,1.61e-07,9;UBERON:0003082,1.61e-07,9;UBERON:0003059,1.61e-07,9;UBERON:0007282,1.61e-07,9;UBERON:0004290,1.61e-07,9;UBERON:0009618,1.61e-07,9;UBERON:0000383,8.12e-07,10 | |||
|phase1_expression=0,0,0,0,0,0,0,0.774739940649458,0.281577444303333,0.234064526321993,0,0,1.36960583944965,1.39872643870396,0.666219523631325,1.01237633694913,0.699561878128147,0.788655413395594,1.37114433605739,0,0,0,0,0,0,0,0,0.215471232685889,0,0,0,0,0,0,0,0,0,8.78916424547506,4.6880120671428,6.28228492768558,38.8232782100469,37.5675016727145,15.0508209439658,0,0,0,0,0,0,0,0,0,2.01339127269284,1.45072428402269,2.01656279485478,0,0,0,0,0,0,0,0,0,0.988866362566974,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.479260498023681,0,0.254140454146129,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.189106080167819,0,0,0,0,0,0,0,0.257347907114715,0.284163499395593,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.324270453550071,0,0,0,0,0,0,0,0.554259570499814,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.252470927204373,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.849892149969277,0.279902904647316,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.409231043169689,0,0,0,0,0,0,0,0 | |||
|short_description=p@chr11:118007387..118007405,+ | |||
}} |
Latest revision as of 13:23, 5 August 2015
Short description: | p@chr11:118007387..118007405, + |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_at_chr11:118007387..118007405, + |
Coexpression cluster: | MCL_coexpression_mm9:6 |
Association with transcript: | NA |
EntrezGene: | NA |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
lymphoid lineage restricted progenitor cell | 7.02e-14 | 12 |
lymphocyte | 8.15e-13 | 13 |
common lymphoid progenitor | 8.15e-13 | 13 |
hematopoietic lineage restricted progenitor cell | 1.77e-12 | 25 |
mature alpha-beta T cell | 4.24e-12 | 9 |
alpha-beta T cell | 4.24e-12 | 9 |
immature T cell | 4.24e-12 | 9 |
mature T cell | 4.24e-12 | 9 |
immature alpha-beta T cell | 4.24e-12 | 9 |
T cell | 5.98e-10 | 11 |
pro-T cell | 5.98e-10 | 11 |
leukocyte | 8.44e-10 | 17 |
nongranular leukocyte | 8.44e-10 | 17 |
hematopoietic cell | 1.21e-09 | 32 |
hematopoietic oligopotent progenitor cell | 1.21e-09 | 32 |
hematopoietic stem cell | 1.21e-09 | 32 |
hematopoietic multipotent progenitor cell | 1.21e-09 | 32 |
CD8-positive, alpha-beta T cell | 4.10e-08 | 1 |
lymphocyte of B lineage | 4.80e-08 | 1 |
B cell | 4.80e-08 | 1 |
pro-B cell | 4.80e-08 | 1 |
CD4-positive, alpha-beta T cell | 5.29e-08 | 8 |
multi-potent skeletal muscle stem cell | 1.61e-07 | 9 |
Ontology term | p-value | n |
---|---|---|
skeletal muscle tissue | 1.61e-07 | 9 |
striated muscle tissue | 1.61e-07 | 9 |
muscle tissue | 1.61e-07 | 9 |
multilaminar epithelium | 1.61e-07 | 9 |
epithelial vesicle | 1.61e-07 | 9 |
musculature | 1.61e-07 | 9 |
somite | 1.61e-07 | 9 |
myotome | 1.61e-07 | 9 |
presomitic mesoderm | 1.61e-07 | 9 |
presumptive segmental plate | 1.61e-07 | 9 |
dermomyotome | 1.61e-07 | 9 |
trunk paraxial mesoderm | 1.61e-07 | 9 |
musculature of body | 8.12e-07 | 10 |
Ontology term | p-value | n |
---|---|---|
musculoskeletal system cancer | 2.08e-21 | 3 |
muscle cancer | 2.08e-21 | 3 |
organ system cancer | 5.11e-11 | 6 |